Additive prognostic value of interleukin-6 at peak phase of dobutamine stress echocardiography in patients with coronary artery disease. A 6-year follow-up study

American Heart Journal

Volumn 156, Issue 2, 2008, Pages 269-276

  Ikonomidis, Ignatios ^a   Athanassopoulos, George ^b   Stamatelopoulos, Kimon ^c   Lekakis, John ^a   Revela, Ioanna ^a   Venetsanou, Kiriaki ^a   Marinou, Margarita ^b   Monaco, Claudia ^c   Cokkinos, Dennis V ^b   Nihoyannopoulos, Petros ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; INTERLEUKIN 6;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RISK FACTOR; STRESS ECHOCARDIOGRAPHY; VASCULAR DISEASE; WALL MOTION SCORE INDEX;

AGED; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; INTERLEUKIN-6; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; THROMBOPLASTIN;

EID: 47649112568     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.03.020     Document Type: Article

References (26)

1. Pingitore A., Picano E., Varga A., et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. J Am Coll Cardiol 34 (1999) 1769-1777
2. Marwick T., Case C., Sawada S., et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 37 (2001) 754-760
3. Biagini E., Elhendy A., Bax J., et al. Seven-year follow-up after dobutamine stress echocardiography. Impact of gender on prognosis. J Am Coll Cardiol 45 (2005) 93-97
4. Sicari R., Pasanisi E., Venneri L., et al. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 41 (2003) 589-595
5. Tsutsui J.M., Elhendy A., Anderson J.R., et al. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 112 (2005) 1444-1450
6. Bjork Ingul C., Rozis E., Slordahl S.A., et al. Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography. Circulation 115 (2007) 1252-1259
7. Sozzi F.B., Elhendy A., Roelandt J.R., et al. Long-term prognosis after normal dobutamine stress echocardiography. Am J Cardiol 92 (2003) 1267-1270
8. Ikonomidis I., Stamatelopoulos K., Lekakis J., et al. Inflammatory markers in coronary artery disease: pathophysiological mechanisms, prognostic and therapeutic implications. Curr Cardiol Rev 2 (2006) 173-184
9. Koukkunen H., Penttila K., Kemppainen A., et al. C-Reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 33 (2001) 37-47
10. Fisman E.Z., Benderly M., Esper R.J., et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 98 (2006) 14-18
11. Hoffmeister A., Rothenbacher D., Kunze M., et al. Prognostic value of inflammatory markers alone and in combination with blood lipids in patients with stable coronary artery disease. Eur J Intern Med 16 (2005) 47-52
12. Ikonomidis I., Athanassopoulos G., Lekakis J., et al. Myocardial ischaemia induces interleukin 6 and tissue factor production in patients with coronary artery disease. A dobutamine stress echocardiography study. Circulation 112 (2005) 3272-3279
13. Finkel M.S., Hoffman R.A., Shen L., et al. Interleukin 6 as a mediator of stunned myocardium. Am J Cardiol 71 (1993) 1231-1232
14. Tsoukas A., Ikonomidis I., Cokkinos P., et al. Significance of persistent left ventricular dysfunction during recovery after dobutamine stress echocardiography. J Am Coll Cardiol 30 (1997) 621-626
15. Sawada S.G., Segar D.S., Ryan T., et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 83 (1991) 1605-1614
16. Hoffmann R., Lethen H., Kühl H., et al. Extent and severity of test positivity during dobutamine stress echocardiography: influence on the predictive value for coronary artery disease. Eur Heart J 20 (1999) 1485-1492
17. Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107 (2003) 149-158
18. Juul-Mollers S., Edvardsson N., Jahnmatz B., et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 340 (1992) 1421-1425
19. Picano E., Lattanzi F., Orlandini A., et al. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 17 (1991) 666-669
20. Wassmann S., Stumpf M., Strehlow K., et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94 (2004) 534-541
21. Szotowski B., Antoniak S., Poller W., et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ. Res 96 (2005) 1233-1239
22. Kukielka G.L., Smith C.W., Manning A.M., et al. Induction of interleukin-6 synthesis in the myocardium. Potential role in post-perfusion inflammatory injury. Circulation 92 (1995) 1866-1875
23. Deng M.C., Erren M., Lütgen A., et al. Interleukin 6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure. Int J Cardiol 57 (1996) 129-134
24. James S.K., Oldgren J., Lindbäck J., et al. An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease. Am Heart J 149 (2005) 619-626
25. Deliargyris E., Raymond R.J., Theoharides T.C., et al. Sites of interleukin 6 in patients with acute coronary syndromes and in patients with congestive heart failure. Am J Cardiol 86 (2000) 913-918
26. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 145-153